MS Roth
Impact in
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 10
- Chronic Myeloid Leukemia Treatments 8
- Acute Myeloid Leukemia Research 3
- Blood groups and transfusion 2
- Hematopoietic Stem Cell Transplantation 2
-
- Eosinophilic Disorders and Syndromes 5
- Co-authors
- JH Antin (4 shared papers)David Ginsburg (1 shared paper)Peter van Tuinen (2 shared papers)Gerald A. Hanson (2 shared papers)JL Gottschall (2 shared papers)Patrick McFadden (2 shared papers)CA Keever (2 shared papers)Susanne Koethe (2 shared papers)
- Journals
- Blood (9 papers)PubMed (5 papers)
- Partner nations
- United StatesPoland
In The Last Decade
MS Roth
14 papers receiving 701 citations
Peers
Comparison fields: 5 of 48
- Hematology 551
- Genetics 171
- Immunology 175
- Transplantation 15
- Rheumatology 71
Countries citing papers authored by MS Roth
This map shows the geographic impact of MS Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MS Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MS Roth more than expected).
Fields of papers citing papers by MS Roth
This network shows the impact of papers produced by MS Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MS Roth. The network helps show where MS Roth may publish in the future.
Co-authors
The 16 scholars most cited alongside MS Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 278 | |
| 2 | 1989 | 153 | |
| 3 | 1992 | 119 | |
| 4 | 1992 | 67 | |
| 5 | Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. | 1992 | 39 |
| 6 | Regressing atypical histiocytosis: a review and critical appraisal. | 1987 | 29 |
| 7 | 1993 | 11 | |
| 8 | 1988 | 6 | |
| 9 | 1989 | 5 | |
| 10 | 1992 | 4 | |
| 11 | 1992 | 4 | |
| 12 | Assessing the economic value of antihypertensive medications. | 1998 | 3 |
| 13 | Application of the polymerase chain reaction for detection of minimal residual disease of hematologic malignancies. | 1991 | 2 |
| 14 | Large endometrioma occurring in an adolescent. | 1977 | 2 |
About MS Roth
MS Roth is a scholar working on Hematology, Rheumatology, Genetics, Immunology and Management of Technology and Innovation, having authored 14 papers that have together received 722 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (8 papers), Eosinophilic Disorders and Syndromes (5 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Blood donation and transfusion practices (2 papers), T-cell and B-cell Immunology (2 papers), Blood groups and transfusion (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Hematology (551 citations), Genetics (171 citations), Immunology (175 citations), Transplantation (15 citations) and Rheumatology (71 citations). MS Roth has collaborated with scholars based in United States and Poland. Frequent co-authors include JH Antin, David Ginsburg, Peter van Tuinen, Gerald A. Hanson, JL Gottschall, Patrick McFadden, CA Keever, Susanne Koethe, RC Ash and William R. Drobyski. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.